ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients (TIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01270347
Recruitment Status : Completed
First Posted : January 5, 2011
Last Update Posted : January 19, 2018
Sponsor:
Collaborator:
Forest Laboratories
Information provided by (Responsible Party):
Horizon Pharma USA, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2012
  Actual Study Completion Date : June 2013
  Certification/Extension First Submitted : January 17, 2018